These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35595574)

  • 1. CRISPR-Cas-mediated diagnostics.
    Li L; Shen G; Wu M; Jiang J; Xia Q; Lin P
    Trends Biotechnol; 2022 Nov; 40(11):1326-1345. PubMed ID: 35595574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-generation pathogen diagnosis with CRISPR/Cas-based detection methods.
    Wang X; Shang X; Huang X
    Emerg Microbes Infect; 2020 Dec; 9(1):1682-1691. PubMed ID: 32643563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of CRISPR-Mediated Nucleic Acid Detection Technologies and Their Applications in the Livestock Industry.
    Zhang X
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas Advancement in Molecular Diagnostics and Signal Readout Approaches.
    Ahmed MZ; Badani P; Reddy R; Mishra G
    J Mol Diagn; 2021 Nov; 23(11):1433-1442. PubMed ID: 34454111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas Systems towards Next-Generation Biosensing.
    Li Y; Li S; Wang J; Liu G
    Trends Biotechnol; 2019 Jul; 37(7):730-743. PubMed ID: 30654914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas assisted diagnostics of plant viruses and challenges.
    Jaybhaye SG; Chavhan RL; Hinge VR; Deshmukh AS; Kadam US
    Virology; 2024 Sep; 597():110160. PubMed ID: 38955083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleic Acid Detection Using CRISPR/Cas Biosensing Technologies.
    Aman R; Mahas A; Mahfouz M
    ACS Synth Biol; 2020 Jun; 9(6):1226-1233. PubMed ID: 32159950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas-based techniques for pathogen detection: Retrospect, recent advances, and future perspectives.
    Huang T; Zhang R; Li J
    J Adv Res; 2023 Aug; 50():69-82. PubMed ID: 36367481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas based diagnostic tools: Bringing diagnosis out of labs.
    Chhipa AS; Radadiya E; Patel S
    Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116252. PubMed ID: 38479094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR Cas system: A strategic approach in detection of nucleic acids.
    Fapohunda FO; Qiao S; Pan Y; Wang H; Liu Y; Chen Q; Lü P
    Microbiol Res; 2022 Jun; 259():127000. PubMed ID: 35338974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Based Precision Molecular Diagnostics for Disease Detection and Surveillance.
    Kulkarni A; Tanga S; Karmakar A; Hota A; Maji B
    ACS Appl Bio Mater; 2023 Oct; 6(10):3927-3945. PubMed ID: 37788375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and therapy with CRISPR advanced CRISPR based tools for point of care diagnostics and early therapies.
    Uppada V; Gokara M; Rasineni GK
    Gene; 2018 May; 656():22-29. PubMed ID: 29496558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating CRISPR/Cas within isothermal amplification for point-of-Care Assay of nucleic acid.
    Zhang L; Jiang H; Zhu Z; Liu J; Li B
    Talanta; 2022 Jun; 243():123388. PubMed ID: 35303554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CRISPR-based molecular diagnostics: a review].
    Sun W; Huang X; Wang X
    Sheng Wu Gong Cheng Xue Bao; 2023 Jan; 39(1):60-73. PubMed ID: 36738201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas-Integrated LAMP.
    Atçeken N; Yigci D; Ozdalgic B; Tasoglu S
    Biosensors (Basel); 2022 Nov; 12(11):. PubMed ID: 36421156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CRISPR-Cas toolbox for analytical and diagnostic assay development.
    Tang Y; Gao L; Feng W; Guo C; Yang Q; Li F; Le XC
    Chem Soc Rev; 2021 Nov; 50(21):11844-11869. PubMed ID: 34611682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small nucleic acids and the path to the clinic for anti-CRISPR.
    Barkau CL; O'Reilly D; Eddington SB; Damha MJ; Gagnon KT
    Biochem Pharmacol; 2021 Jul; 189():114492. PubMed ID: 33647260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR diagnostics: Underappreciated uses in perinatology.
    Pan A; Kraschel KL
    Semin Perinatol; 2018 Dec; 42(8):525-530. PubMed ID: 30415764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in CRISPR sensing and detection technology].
    Wang J; Zhao P; Qin M; Zhao Y; Liu C; Xia X
    Sheng Wu Gong Cheng Xue Bao; 2024 Feb; 40(2):367-377. PubMed ID: 38369827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the use of the CRISPR-Cas system for the detection of infectious pathogens.
    Gao H; Shang Z; Chan SY; Ma D
    J Zhejiang Univ Sci B; 2022 Nov; 23(11):881-898. PubMed ID: 36379609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.